Literature DB >> 19094828

Changes in the clinical epidemiology of HIV infection in the United States: implications for the clinician.

Kate Buchacz1, Maria Rangel, Rachel Blacher, John T Brooks.   

Abstract

The HIV epidemic in the United States continues to affect racial/ethnic minorities disproportionately and is increasing among men who have sex with men. Late HIV diagnosis remains common. To reduce HIV transmission and facilitate early linkage to care and antiretroviral treatment, the Centers for Disease Control and Prevention recommends universal voluntary HIV screening for all persons ages 13 to 64 years in public and private care settings. Recent studies demonstrate dramatic reductions in morbidity and mortality with widespread use of highly active combination antiretroviral therapy (cART), and some document improved outcomes when cART is initiated with CD4 cell count >/= 350 cells/mm(3). As patients live longer, they are increasingly affected by chronic diseases, notably cardiovascular and renal disease, diabetes, and non-AIDS-defining cancers. Providers should ensure patients undertake preventive lifestyle changes (eg, smoking cessation, exercise, weight loss, dietary modification) and undergo recommended screening tests to reduce their risk for these important comorbidities.

Entities:  

Year:  2009        PMID: 19094828     DOI: 10.1007/s11908-009-0011-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  56 in total

1.  Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study.

Authors:  Benjamin Young; Kate Buchacz; Rose K Baker; Anne C Moorman; Kathy C Wood; Joan Chmiel; John T Brooks
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2007-06-19

2.  The Young Men's Survey phase II: hepatitis B immunization and infection among young men who have sex with men.

Authors:  Cindy M Weinbaum; Rob Lyerla; Duncan A Mackellar; Linda A Valleroy; Gina M Secura; Stephanie K Behel; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene Lalota; Douglas A Shehan; Hanne Thiede; Lucia V Torian
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

3.  Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).

Authors:  Angeles Jaén; Anna Esteve; Josep M Miró; Cristina Tural; Alexandra Montoliu; Elena Ferrer; Melcior Riera; Ferran Segura; Lluis Force; Omar Sued; Josep Vilaró; Isabel Garcia; Angels Masabeu; Jordi Altès; Bonaventura Coltet; Daniel Podzamczer; Javier Murillas; Gemma Navarro; Josep M Gatell; Jordi Casabona
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

4.  Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

Authors:  Kate Buchacz; Rose K Baker; Anne C Moorman; James T Richardson; Kathleen C Wood; Scott D Holmberg; John T Brooks
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

5.  Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

Authors:  Handan Wand; Alexandra Calmy; Dianne L Carey; Katherine Samaras; Andrew Carr; Matthew G Law; David A Cooper; Sean Emery
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

6.  Chronic kidney disease in HIV infection: an urban epidemic.

Authors:  Christina M Wyatt; Jonathan A Winston; Carlos D Malvestutto; Dawn A Fishbein; Irina Barash; Alan J Cohen; Mary E Klotman; Paul E Klotman
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

7.  Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Authors:  Miguel Goicoechea; Shanshan Liu; Brookie Best; Shelly Sun; Sonia Jain; Carol Kemper; Mallory Witt; Catherine Diamond; Richard Haubrich; Stan Louie
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.

Authors:  Kathryn Anastos; Dalian Lu; Qiuhu Shi; Phyllis C Tien; Robert C Kaplan; Nancy A Hessol; Steven Cole; Cheryl Vigen; Mardge Cohen; Mary Young; Jessica Justman
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

9.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

10.  The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

Authors:  Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

View more
  5 in total

1.  The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough.

Authors:  Ava Lorenc; Piriyankan Ananthavarathan; James Lorigan; Mohamade Jowata; Gary Brook; Ricky Banarsee
Journal:  London J Prim Care (Abingdon)       Date:  2014

2.  Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic.

Authors:  Jeffrey J Weiss; Georgina Osorio; Elizabeth Ryan; Sue M Marcus; Dawn A Fishbein
Journal:  AIDS Patient Care STDS       Date:  2010-01       Impact factor: 5.078

3.  Changes in the socio-demographics, risk behaviors, clinical and immunological profile of a cohort of the Puerto Rican population living with HIV: an update of the Retrovirus Research Center (1992-2008).

Authors:  Christine Miranda; Diana M Fernandez; Raul O Ramon; Miriam Velázquez; Angel M Mayor; Robert F Hunter-Mellado
Journal:  Bol Asoc Med P R       Date:  2010 Jul-Sep

4.  Associations and Trends in Cause-Specific Rates of Death Among Persons Reported with HIV Infection, 23 U.S. Jurisdictions, Through 2011.

Authors:  William K Adih; Richard M Selik; H Irene Hall; Aruna Surendera Babu; Ruiguang Song
Journal:  Open AIDS J       Date:  2016-07-29

5.  At the coalface and the cutting edge: general practitioners' accounts of the rewards of engaging with HIV medicine.

Authors:  Christy E Newman; Asha Persson; John B F de Wit; Robert H Reynolds; Peter G Canavan; Susan C Kippax; Michael R Kidd
Journal:  BMC Fam Pract       Date:  2013-03-21       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.